Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 94, Issue 12, 2004, Pages 1515-1522

  Monakier, Daniel ^b   Woo, Anna ^b   Puri, Timothy ^b   Schwartz, Leonard ^b   Ross, John ^b   Jamorski, Michal ^b   Yang, Hua ^b   Liu, Zheng ^b   Vannan, Mani ^b   Wigle, E Douglas ^b   Rakowski, Harry ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CREATINE KINASE;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CALCULATION; CARDIOVASCULAR RISK; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY; DEATH; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GENERAL HOSPITAL; HEART HYPERTROPHY; HEART INFARCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE; HEART SIZE; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INJECTION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; NONSURGICAL INVASIVE THERAPY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; REST; RISK ASSESSMENT; SEPTAL ETHANOL ABLATION; SYSTOLE; TREATMENT OUTCOME; CATHETER ABLATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART BLOCK; HYPERTROPHIC CARDIOMYOPATHY; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ETHANOL; FEMALE; HEART BLOCK; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MYOCARDIAL INFARCTION; PACEMAKER, ARTIFICIAL; TREATMENT OUTCOME;

EID: 13944284173     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.08.030     Document Type: Article

References (16)

1. Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quinones MA, Tajik AJ, Spencer WH. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001 15;38:1701-1706.
2. F.H. Gietzen, C.J. Leuner, U. Raute-Kreinsen, A. Dellmann, J. Hegselmann, C. Strunk-Mueller, H.J. Kuhn Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH) Catheter interventional treatment for hypertrophic obstructive cardiomyopathy Eur Heart J 20 1999 1342 1354
3. R.B. McCully, R.A. Nishimura, J. Tajik, H.W. Schaff, G.K. Danielson Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy Circulation 94 1996 467 471
4. N. Cregg, D.C. Cheng, J.M. Karski, W.G. Williams, G. Webb, E.D. Wigle Morbidity outcome in patients with hypertrophic obstructive cardiomyopathy undergoing cardiac septal myectomy: early-extubation anesthesia versus high-dose opioid anesthesia technique J Cardiothorac Vasc Anesth 13 1999 47 52
5. B. Heric, B.W. Lytle, D.P. Miller, E.R. Rosenkranz, H.M. Lever, D.M. Cosgrove Surgical management of hypertrophic obstructive cardiomyopathy Early and late results J Thorac Cardiovasc Surg 110 1995 195 206
6. H. Rakowski, Z. Sasson, E.D. Wigle Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy J Am Soc Echocardiogr 1 1988 31 47
7. R. Bhagwandeen, A. Woo, J. Ross, E.D. Wigle, H. Rakowski, J. Kwinter, M.J. Eriksson, L. Schwartz Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre Can J Cardiol 19 2003 912 917
8. Kaul S, Senior R, Dittrich H, Raval U, Khattar R, Lahiri A. Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99m Tc-sestamibi single-photon emission computed tomography. Circulation 1997;785-792.
9. E.L. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
10. D.R. Cox Regression models and life-tables J R Stat Soc B 34 1972 187 220
11. P. Kaufmann, G. Vassalli, S. Lupi-Wagner, R. Jenni, O.M. Hess Coronary artery dimensions in primary and secondary left ventricular hypertrophy J Am Coll Cardiol 28 1996 745 750
12. N.M. Lakkis, S.F. Nagueh, J.K. Dunn, D. Killip, W.H. Spencer III Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up J Am Coll Cardiol 36 2000 852 855
13. H. Kuhn, H. Seggewiss, F.H. Gietzen, P. Boekstegers, L. Neuhaus, L. Seipel Catheter-based therapy for hypertrophic obstructive cardiomyopathy First in-hospital outcome analysis of the German TASH Registry Z Kardiol 93 2004 23 31
14. V.L. Fernandes, S.F. Nagueh, N.M. Lakkis, J. Franklin, R. Roberts, W.H. Spencer III The long-term follow-up results of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: the Baylor experience (1996-2001) J Am Coll Cardiol 39 suppl 2002 157A
15. S.F. Nagueh, N.M. Lakkis, Zx He, K.J. Middleton, D. Killip, W.A. Zoghbi, M.A. Quinones, R. Roberts, M.S. Verani, N.S. Kleiman, W.H. Spencer III Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 32 1998 225 229
16. W.G. van Dockum, F.J. ten Cate, J.M. ten Berg, A.M. Beek, J.W. Twisk, J. Vos, M.B. Hofman, C.A. Visser, A.C. van Rossum Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging J Am Coll Cardiol 43 2004 27 34